Healthcare Analysts discuss what is new and on the horizon (relevant companies ANTX INSM MNKD SPRO) for treatment of the Non-Tuberculosis Mycobacteria Lung Disease on an Analyst/Industry conference call to be held on February 24.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANTX: